SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma
5 references·2 citing·26 second hop
Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma (2009)Cost-Effectiveness of Temsirolimus for Fi…Modelling the monetary value of a QALY: a new approach based on UK data (2008)Modelling the monetary value …Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastatic Renal Cell Carcinoma (2008)Economic Evaluation of Suniti…Methodological issues in the economic analysis of cancer treatments (2006)Methodological issues in the …Decision Modelling For Health Economic Evaluation (2006)Decision Modelling For Health…Methods for the analysis of quality-of-life and survival data in health technology assessment. (1999)Methods for the analysis of q…Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China (2018)Cost-effectiveness of afatini…Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy (2014)Cost-effectiveness analysis o…Cost-Effectiveness in Health and Medicine (1996)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)Measuring Outcomes in Palliative Care: Limitations of QALYs and the Road to PalYs (2009)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Economic Evaluation in Health Care: Merging Theory with Practice (2002)National Institute for Clinical Excellence and its value judgments (2004)Economic foundations of cost-effectiveness analysis (1997)Willingness to Pay for a Quality-adjusted Life Year (2000)Trying to estimate a monetary value for the QALY (2009)The social value of a QALY: raising the bar or barring the raise? (2011)Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds (2021)Development of WHO guidelines on generalized cost-effectiveness analysis (2000)Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? (2004)China's health system and its reform: a review of recent studies (2009)Health state utilities for non small cell lung cancer (2008)Consistency and inconsistency in network meta‐analysis: concepts and models for multi‐arm studies (2012)Model Parameter Estimation and Uncertainty Analysis (2012)Statistical principles in experimental design. (1962)Statistical Principles in Experimental Design (1964)Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines (1993)BEST PRACTICE IN UNDERTAKING AND REPORTING HEALTH TECHNOLOGY ASSESSMENTS (2002)Calculation of quality adjusted life years in the published literature: a review of methodology and transparency (2004)The cost-effectiveness of screening for oral cancer in primary care (2006)Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6 (2012)Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 (2012)
this work references cited by second hop

References

  • 2006Decision Modelling For Health Economic Evaluation3,144 cited
  • 1999Methods for the analysis of quality-of-life and survival data in health technology assessment.307 cited
  • 2008Modelling the monetary value of a QALY: a new approach based on UK data113 cited
  • 2006Methodological issues in the economic analysis of cancer treatments107 cited
  • 2008Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastatic Renal Cell Carcinoma88 cited

Cited by

  • 2014Cost-effectiveness analysis of adjuvant chemotherapies in patients presenting with gastric cancer after D2 gastrectomy72 cited
  • 2018Cost-effectiveness of afatinib, gefitinib, erlotinib and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China71 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work